Document is current

Any future updates will be listed below

Mortality and persistence in therapy in elderly subjects with type 2 diabetes receiving gliflozins or incretins

Crossref DOI link: https://doi.org/10.1007/s40618-026-02994-1

Published Online: 2026-07-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark